Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) — Denver, Colorado

Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) has participated in 1 clinical trials.

Therapeutic areas: Carcinoid Tumor, Malignant Carcinoid Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers Dept of Rocky Mountain (2)?

Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) conducted?

Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) has 1 clinical trials on record. Their work covers Carcinoid Tumor, Malignant Carcinoid Syndrome.

Is Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) accredited by Crixeo Health?

Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers Dept of Rocky Mountain (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.